ascopubs.org

Understanding the Role of Comparative Clinical Studies in the Development of Oncology Biosimilars

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial ...

Positive Clinical Results from HyBryte(TM) Comparative Study Evaluating HyBryte(TM) Against Valchlor(R) in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
National Academies of Sciences%2c Engineering%2c and Medicine

International Comparative Studies in Education: Descriptions of Selected Large-Scale Assessments and Case Studies

Unfortunately, this book can't be printed from the OpenBook. Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
ascopubs.org

Real-world comparative outcomes of chemo-immunotherapy versus chemotherapy in colon cancer: A multi-center retrospective cohort study.

Impact of KRAS mutation status on outcomes in peritoneal metastatic mucinous adenocarcinoma of the colon and appendix following CRS-HIPEC: A retrospective analysis. The addition of monoclonal ...

SOLIGENIX, INC.: Positive Clinical Results from HyBryte Comparative Study Evaluating HyBryte Against Valchlor in the Treatment of Cutaneous T-Cell Lymphoma Published in ...

HyBryte demonstrates more rapid and robust treatment response compared toValchlor® during 12-week treatment course PRINCETON, N.J., April 2, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ...